Andre Broermann

1.2k total citations
15 papers, 945 citations indexed

About

Andre Broermann is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Andre Broermann has authored 15 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Andre Broermann's work include Liver Disease Diagnosis and Treatment (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Andre Broermann is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Angiogenesis and VEGF in Cancer (6 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Andre Broermann collaborates with scholars based in Germany, United States and Denmark. Andre Broermann's co-authors include Dietmar Vestweber, Alexander Zarbock, Dörte Schulte, Olena Kamenyeva, Friedemann Kiefer, Alexander G. Khandoga, Hang Li, Mark Winderlich, Giuseppe Cagna and Astrid F. Nottebaum and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and The EMBO Journal.

In The Last Decade

Andre Broermann

15 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andre Broermann Germany 12 458 237 165 146 145 15 945
Yves Rival France 12 521 1.1× 249 1.1× 239 1.4× 238 1.6× 73 0.5× 15 1.1k
Matina Economopoulou Germany 14 363 0.8× 346 1.5× 123 0.7× 84 0.6× 177 1.2× 21 1.1k
Floris P. J. van Alphen Netherlands 18 481 1.1× 423 1.8× 118 0.7× 102 0.7× 77 0.5× 47 1.3k
Jessica Pruessmeyer Germany 14 611 1.3× 252 1.1× 375 2.3× 149 1.0× 77 0.5× 15 1.3k
Line Fraemohs Germany 10 351 0.8× 321 1.4× 350 2.1× 125 0.9× 54 0.4× 10 967
Chongxiu Sun United States 14 296 0.6× 267 1.1× 82 0.5× 75 0.5× 88 0.6× 21 880
Beatriz Marcos‐Ramiro Spain 12 398 0.9× 116 0.5× 93 0.6× 197 1.3× 59 0.4× 15 740
Michael Broman United States 18 615 1.3× 123 0.5× 139 0.8× 231 1.6× 57 0.4× 34 1.3k
M L Entman United States 14 392 0.9× 485 2.0× 402 2.4× 122 0.8× 81 0.6× 14 1.3k
Kameran Lashkari United States 18 704 1.5× 177 0.7× 73 0.4× 85 0.6× 79 0.5× 59 1.6k

Countries citing papers authored by Andre Broermann

Since Specialization
Citations

This map shows the geographic impact of Andre Broermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andre Broermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andre Broermann more than expected).

Fields of papers citing papers by Andre Broermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andre Broermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andre Broermann. The network helps show where Andre Broermann may publish in the future.

Co-authorship network of co-authors of Andre Broermann

This figure shows the co-authorship network connecting the top 25 collaborators of Andre Broermann. A scholar is included among the top collaborators of Andre Broermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andre Broermann. Andre Broermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Veidal, Sanne Skovgård, Denise Oró, Agnete Overgaard, et al.. (2022). Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH. Clinical and Translational Science. 15(5). 1167–1186. 45 indexed citations
2.
Oldenburger, Anouk, Gerald Birk, Andre Broermann, et al.. (2021). Modulation of vascular contraction via soluble guanylate cyclase signaling in a novel ex vivo method using rat precision‐cut liver slices. Pharmacology Research & Perspectives. 9(3). e00768–e00768. 5 indexed citations
3.
Veyel, Daniel, Andre Broermann, Tom Bretschneider, et al.. (2020). Biomarker discovery for chronic liver diseases by multi-omics – a preclinical case study. Scientific Reports. 10(1). 1314–1314. 29 indexed citations
4.
Broermann, Andre, Ramona Schmid, Sascha Keller, et al.. (2020). Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl4 Treated Rats. International Journal of Molecular Sciences. 22(1). 382–382. 19 indexed citations
5.
Bigaeva, Emilia, Anouk Oldenburger, Detlef Schuppan, et al.. (2020). Investigating fibrosis and inflammation in an ex vivo NASH murine model. American Journal of Physiology-Gastrointestinal and Liver Physiology. 318(2). G336–G351. 17 indexed citations
6.
Tølbøl, K.S., Birgit Stierstorfer, Jörg F. Rippmann, et al.. (2018). Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences. 64(5). 1238–1256. 18 indexed citations
7.
Bretschneider, Tom, et al.. (2017). Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis. British Journal of Pharmacology. 175(4). 693–707. 16 indexed citations
8.
Lewis, Nuruddeen D., Lori Patnaude, Josephine Pelletier, et al.. (2014). A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo. PLoS ONE. 9(6). e100883–e100883. 54 indexed citations
9.
Schulte, Dörte, Verena Küppers, Andre Broermann, et al.. (2011). Stabilizing the VE‐cadherin–catenin complex blocks leukocyte extravasation and vascular permeability. The EMBO Journal. 30(20). 4157–4170. 222 indexed citations
10.
Broermann, Andre, Mark Winderlich, Helena Block, et al.. (2011). Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. The Journal of Experimental Medicine. 208(12). 2393–2401. 157 indexed citations
11.
Broermann, Andre, Mark Winderlich, Helena Block, et al.. (2011). Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. The Journal of Cell Biology. 195(3). i4–i4. 2 indexed citations
12.
Vestweber, Dietmar, Andre Broermann, & Dörte Schulte. (2010). Control of endothelial barrier function by regulating vascular endothelial-cadherin. Current Opinion in Hematology. 17(3). 230–236. 36 indexed citations
13.
Petri, Björn, Andre Broermann, Hang Li, et al.. (2010). von Willebrand factor promotes leukocyte extravasation. Blood. 116(22). 4712–4719. 174 indexed citations
14.
Winderlich, Mark, Giuseppe Cagna, Andre Broermann, et al.. (2009). VE-PTP controls blood vessel development by balancing Tie-2 activity. The Journal of Cell Biology. 185(4). 657–671. 146 indexed citations
15.
Winderlich, Mark, Giuseppe Cagna, Andre Broermann, et al.. (2009). VE-PTP controls blood vessel development by balancing Tie-2 activity. The Journal of Experimental Medicine. 206(6). i11–i11. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yves Rival Breakdown of academic impact, for papers by Matina Economopoulou Breakdown of academic impact, for papers by Floris P. J. van Alphen Breakdown of academic impact, for papers by Jessica Pruessmeyer Breakdown of academic impact, for papers by Line Fraemohs Breakdown of academic impact, for papers by Chongxiu Sun Breakdown of academic impact, for papers by Beatriz Marcos‐Ramiro Breakdown of academic impact, for papers by Michael Broman Breakdown of academic impact, for papers by M L Entman Breakdown of academic impact, for papers by Kameran Lashkari
Rankless by CCL
2026